Cynthia D. Brown - Concepedia

Author

Cynthia D. Brown

Indiana University School of Medicine ORCID

Also Known As

C Brown, C. BROWN, C. Brown, C.D. Brown, Cynthia Brown, Cynthia D Brown, Cynthia D. Brown, Jeremy Brown, Joseph M Pilewski, Maria Veronica Indihar

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Indiana University School of Medicine Indiana University – Purdue University Indianapolis University of Alabama at Birmingham Brigham and Women's Hospital National Jewish Health

About

Cynthia D. Brown is an author at Indiana University School of Medicine specializing in medicine, epidemiology, and depression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	365
2	Health Sciences	2	2	73
3	Language Studies	1	1	21
4	Public Health	1	1	14
5	Allergy	1	1	119

Cynthia D. Brown

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles Jane C. Davies, Samuel M. Moskowitz, Cynthia D. Brown, New England Journal of Medicine	2018	320
Health-Related Quality of Life of Persons With Sarcoidosis Christopher E. Cox, James F. Donohue, Cynthia D. Brown, CHEST Journal Quality Of LifeLife AssessmentHuman HealthHealth-related Quality	2004	198
The Sarcoidosis Health Questionnaire Christopher E. Cox, James F. Donohue, Cynthia D. Brown, American Journal of Respiratory and Critical Care Medicine Quality Of LifeClinical FindingPsychopathologySarcoidosis Health QuestionnairePsychiatry	2003	119
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan, Journal of Cystic Fibrosis Pulmonary CareAllergyPulmonary PharmacologyPulmonary FibrosisInterim Results	2023	119
Effects of Sleep Apnea on Nocturnal Free Fatty Acids in Subjects with Heart Failure Jonathan C. Jun, Luciano F. Drager, Samer S. Najjar, SLEEP	2011	62
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials Ahmet Uluer, Gordon MacGregor, Pilar Azevedo, The Lancet Respiratory Medicine MedicinePhase 2	2023	61
Influence of metabolic fuel on the13C/12C ratio of breath CO2 Dale A. Schoeller, Cynthia D. Brown, K Nakamura, Journal of Mass Spectrometry	1984	54
Exercise Testing in Severe Emphysema: Association with Quality of Life and Lung Function Cynthia D. Brown, Joshua O. Benditt, Frank C. Sciurba, COPD Journal of Chronic Obstructive Pulmonary Disease Physical ActivityAdvanced Lung DiseaseSevere EmphysemaLung FunctionSix-minute Walk Testing	2008	52
Speech perception in children using the advanced Speak speech-processing strategy. Robert Cowan, Cynthia D. Brown, Lesley A. Whitford, PubMed Language DevelopmentSpeech Sound DisorderSpeak Speech-processing StrategySpeech ScienceDevelopmental Speech	1995	21
Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor Payal Patel, Jana Yeley, Cynthia D. Brown, International Journal of Neonatal Screening	2023	17

Page 1